This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Alcediag, Centre National De La Recherche Scientifique-Cnrs, Universite Paris Cité. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Bérengère Abou: Innovator in Nano-Rheological Biomarkers
Introduction
Bérengère Abou is a notable inventor based in Paris, France. He has made significant contributions to the field of biomedical diagnostics, particularly in the study of red blood cell (RBC) deformability. His innovative work has the potential to improve the early detection and follow-up of various pathologies associated with RBC deformability alterations.
Latest Patents
Bérengère Abou holds a patent for "Nano-rheological biomarkers for early and improved follow-up of pathologies associated to RBC deformability alteration." This invention focuses on a method to detect alterations in the deformability of RBCs in blood samples. It utilizes molecular rotors (MR) that can penetrate RBC membranes to assess their deformability. The patent also encompasses diagnostic methods for RBC-related pathologies by measuring fluorescence intensity images of RBCs, employing optical techniques. Furthermore, the invention includes the use of MRs for testing RBC deformability in blood samples and a kit comprising MRs and RBC controls.
Career Highlights
Throughout his career, Bérengère Abou has worked with prominent organizations such as Alcediag and the Centre National de la Recherche Scientifique (CNRS). His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Bérengère has collaborated with notable colleagues, including Franck Molina and Thomas Podgorski. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Bérengère Abou is a distinguished inventor whose work in nano-rheological biomarkers is paving the way for advancements in medical diagnostics. His contributions are vital for enhancing the understanding and treatment of RBC-related pathologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile